Equillium (EQ) Institutional Ownership $0.98 +0.05 (+5.39%) Closing price 08/14/2025 04:00 PM EasternExtended Trading$0.97 -0.01 (-1.34%) As of 08:09 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Equillium (NASDAQ:EQ)CurrentInstitutional OwnershipPercentage27.05%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$1.39MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$44.72K Get EQ Insider Trade Alerts Want to know when executives and insiders are buying or selling Equillium stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data EQ Institutional Buying and Selling by Quarter Equillium Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2025 Renaissance Technologies LLC261,400$196K0.0%-18.6%0.738% 2/12/2025 Takeda Pharmaceutical Co. Ltd.1,824,977$1.37M5.2%N/A5.151% 2/11/2025 DCF Advisers LLC62,947$47K0.0%+91.0%0.178% 8/9/2024 Renaissance Technologies LLC300,400$208K0.0%+43.6%0.852% 5/10/2024 Acadian Asset Management LLC108,691$249K0.0%N/A0.308% 2/12/2024 Decheng Capital LLC4,447,308$3.22M0.9%N/A12.663% 8/9/2023 DCF Advisers LLC111,623$84K0.0%-28.9%0.324% 5/2/2023 Victory Capital Management Inc.345,861$252K0.0%-89.2%1.005% 2/14/2023 True North Advisors LLC265,370$265K0.1%+50.5%0.771% 2/13/2023Callan Capital LLC103,688$110K0.0%N/A0.301% Get the Latest News and Ratings for EQ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Equillium and its competitors with MarketBeat's FREE daily newsletter. 2/9/2023 Victory Capital Management Inc.3,198,745$3.52M0.0%-12.4%9.296% 1/24/2023 Capital CS Group LLC24,000$25K0.0%N/A0.070% 11/7/2022 Virtu Financial LLC24,141$54K0.0%N/A0.070% 11/2/2022 Victory Capital Management Inc.3,651,084$8.11M0.0%+2.1%10.651% 8/11/2022 DCF Advisers LLC114,027$233K0.1%-31.2%0.333% 8/1/2022 Victory Capital Management Inc.3,577,211$7.30M0.0%-0.6%10.436% 5/16/2022 Cota Capital Management LLC562,278$1.77M0.4%N/A1.640% 5/10/2022Decheng Capital Management III Cayman LLC4,447,308$14.01M4.3%N/A12.975% 5/4/2022 Victory Capital Management Inc.3,597,799$11.33M0.0%+8.2%10.495% 2/15/2022Samsara BioCapital LLC615,541$2.32M0.5%-16.6%2.094% 2/7/2022 Victory Capital Management Inc.3,325,050$12.47M0.0%+4.9%11.313% 11/16/2021Two Sigma Securities LLC83,948$573K0.0%N/A0.286% 11/12/2021 Geode Capital Management LLC154,185$1.05M0.0%+2.4%0.525% 11/2/2021 Victory Capital Management Inc.3,170,199$21.62M0.0%+9.4%10.789% 8/17/2021Samsara BioCapital LLC738,176$4.35M0.5%-3.4%2.512% 8/17/2021Bridgeway Capital Management LLC141,200$832K0.0%+38.4%0.481% 8/16/2021State Street Corp30,756$181K0.0%N/A0.105% 8/16/2021Goldman Sachs Group Inc.218,162$1.29M0.0%N/A0.742% 8/13/2021 DCF Advisers LLC77,538$457K0.2%N/A0.267% 8/13/2021 Geode Capital Management LLC150,582$886K0.0%+16.7%0.519% 8/13/2021 Vanguard Group Inc.840,545$4.95M0.0%+31.4%2.894% 8/11/2021 Deutsche Bank AG356,461$2.10M0.0%+1.8%1.227% 8/3/2021 Victory Capital Management Inc.2,896,875$17.06M0.0%+1.0%9.975% 5/21/2021Citadel Advisors LLC21,366$153K0.0%N/A0.074% 5/18/2021Millennium Management LLC63,012$451K0.0%+413.3%0.217% (Data available from 1/1/2016 forward) EQ Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of EQ shares? During the previous two years, the following institutional investors and hedge funds held shares of Equillium shares: Decheng Capital LLC ($3.22M), Takeda Pharmaceutical Co. Ltd. ($1.37M), Acadian Asset Management LLC ($249K), and Renaissance Technologies LLC ($196K), DCF Advisers LLC ($47K).Learn more on Equillium's institutional investors. What percentage of Equillium's stock is owned by institutional investors? 27.05% of Equillium's stock is owned by institutional investors. Learn more on EQ's institutional investor holdings. Which institutional investors have been buying Equillium's stock? The following institutional investors have purchased Equillium's stock in the last 24 months: Decheng Capital LLC ($4.45M), Takeda Pharmaceutical Co. Ltd. ($1.82M), Acadian Asset Management LLC ($108.69K), Renaissance Technologies LLC ($91.20K), and DCF Advisers LLC ($29.99K). How much institutional buying is happening at Equillium? Institutional investors have bought a total of 1,854,962 shares in the last 24 months. This purchase volume represents approximately $1.39M in transactions. Which of Equillium's major shareholders have been selling company stock? The following institutional investors have sold Equillium stock in the last 24 months: Renaissance Technologies LLC ($59.77K). How much institutional selling is happening at Equillium? Institutional investors have sold a total of 59,773 shares in the last 24 months. This volume of shares sold represents approximately $44.72K in transactions. Related Companies MacroGenics Institutional Ownership Climb Bio Institutional Ownership Pliant Therapeutics Institutional Ownership Anixa Biosciences Institutional Ownership Oncolytics Biotech Institutional Ownership Zentalis Pharmaceuticals Institutional Ownership Surrozen Institutional Ownership Scilex Institutional Ownership TScan Therapeutics Institutional Ownership Adagene Institutional Ownership This page (NASDAQ:EQ) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Equillium, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Equillium With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access